Home Featured

Featured

Thursday’s Movers and Shakers in Biotech

Jennifer Aldershot - January 14, 2016

Mylan NV (NASDAQ:MYL) Partnership Means the Race is Back on for Mabion SA and Its Billion Dollar Rituximab Biosimilar

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Could Change the Face of Stem Cell Therapy

Ebola Silver Bullet a Social Not Financial Win for Merck

Is the Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP) Delay Cause for Concern?

Gold Bottom Watch, 2008 vs Now

Rafi Farber - October 12, 2015

Fortress Biotech Inc (NASDAQ:FBIO) Spike: Is It Deserved, And What’s Next?

Mark Collins - December 29, 2016

INSYS is Targeting a $700 Million Market With Syndros

Jennifer Aldershot - November 30, 2015

CoLucid Pharmaceuticals Inc (NASDAQ:CLCD): What The Data Means

Mark Collins - September 6, 2016

Biotech Movers: Valeant Pharmaceuticals International, Inc. (NYSE:VRX), Aerie Pharmaceuticals Inc (NASDAQ:AERI)...

Mark Collins - August 17, 2017

Biotech Movers This Week: Galena Biopharma Inc (NASDAQ:GALE) and Oculus Innovative...

Mark Collins - November 2, 2016

Acorda Therapeutics Inc (NASDAQ:ACOR) Targets the Stroke Market with MS Drug

Mark Collins - April 29, 2016

Why the SciVac VBI Merger Makes a Lot of Sense

Mark Collins - October 28, 2015

Here’s What Just Happened With Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)

Mark Collins - July 27, 2017

Is The Epizyme Inc (NASDAQ:EPZM) Dip A Discount Entry Opportunity?

Mark Collins - August 9, 2016

12 3...66 Page 1 of 66

EDITOR PICKS

Biotech Movers: Cardiome Pharma Corp. (NASDAQ:CRME), Coherus BioSciences, Inc. (NASDAQ:CHRS) and...

August 22, 2017

Biotech Movers: Eleven Biotherapeutics Inc (NASDAQ:EBIO) and Horizon Pharma PLC (NASDAQ:HZNP)

August 21, 2017

Here’s What Just Happened With Pfizer Inc. (NYSE:PFE) and AstraZeneca plc...

August 18, 2017

This Small Nasdaq Hidden Gem May Have a $2.8B Drug

July 16, 2017

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.